S. Muoio & Co. LLC F Star Therapeutics, Inc. Call Options Transaction History

S. Muoio & Co. LLC

  • $75.7 Million
  • Q3 2022

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track S. Muoio & Co. LLC Portfolio

Follow S. Muoio & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S. Muoio & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on S. Muoio & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email